1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKETS COVERED 22
1.4 YEARS CONSIDERED FOR THE STUDY 23
1.5 CURRENCY 23
1.6 LIMITATIONS 23
1.7 STAKEHOLDERS 24

2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
2.2 SECONDARY DATA 25
2.2.1 KEY DATA FROM SECONDARY SOURCES 27
2.3 PRIMARY DATA 28
2.3.1 KEY DATA FROM PRIMARY SOURCES 28
2.4 MARKET SIZE ESTIMATION 29
2.4.1 REVENUE MAPPING-BASED MARKET ESTIMATION 30
2.5 DATA TRIANGULATION 32
2.5.1 ASSUMPTIONS FOR THE STUDY 33
2.5.2 RESEARCH LIMITATIONS 33

3 EXECUTIVE SUMMARY 34

4 PREMIUM INSIGHTS 38
4.1 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES:
MARKET OVERVIEW 38
4.2 ASIA PACIFIC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY END USER & COUNTRY (2018) 39
4.3 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE (2017–2024) 40
4.4 GEOGRAPHIC SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET 41

5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS: DRIVERS, RESTRAINTS, AND CHALLENGES 42
5.2.1 DRIVERS 42
5.2.1.1 Increasing incidence of cardiovascular disease 42
5.2.1.2 Technological advancements 43
5.2.1.3 Increasing investments, funds, and grants for research on
CM & CRM devices 44
5.2.1.4 Growing preference for wearable cardiac devices 44
5.2.2 RESTRAINTS 45
5.2.2.1 Increasing incidence of CIED infections 45
5.2.3 CHALLENGES 46
5.2.3.1 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices 46
5.2.3.2 Frequent product recalls 46

6 CARDIAC MONITORING DEVICES MARKET, BY TYPE 47
6.1 INTRODUCTION 48
6.2 ECG DEVICES 49
6.2.1 RESTING ECG DEVICES 50
6.2.1.1 Low cost, ease of use, and simplicity have driven the adoption of resting ECG devices 50
6.2.2 STRESS ECG DEVICES 51
6.2.2.1 Flexibility in use has driven the demand for stress ECG devices, but high cost has negatively affected the market 51
6.2.3 HOLTER MONITORS 52
6.2.3.1 Short duration of monitoring is a key restraint to market growth 52
6.3 IMPLANTABLE LOOP RECORDERS 52
6.3.1 HIGH COST AND LIMITED APPLICATIONS HAVE HINDERED DEMAND GROWTH 52
6.4 MOBILE CARDIAC TELEMETRY DEVICES 54
6.4.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS IS PROPELLING MARKET GROWTH 54
6.5 CARDIAC OUTPUT MONITORING DEVICES 55
6.5.1 INCREASING NUMBER OF CARDIAC SURGERIES WILL DRIVE THE DEMAND FOR COM DEVICES 55
6.6 EVENT MONITORS 57
6.6.1 EVENT MONITORS MARKET, BY TYPE 58
6.6.1.1 Pre-symptom event monitors 59
6.6.1.1.1 Large storage capacity of pre-symptom event monitors makes them ideal for long-term monitoring 59
6.6.1.2 Post-symptom event monitors 59
6.6.1.2.1 Emergence of handheld, wireless, and remote monitors will drive market growth 59
6.6.2 EVENT MONITORS MARKET, BY TECHNOLOGY 60
6.6.2.1 Autodetect monitors 60
6.6.2.1.1 Autodetect monitors are ideal for patients who are unable to reliably trigger monitors 60
6.6.2.2 Manual event monitors 60
6.6.2.2.1 Manual monitors can be pre-symptom or post-symptom, but rely on the patient to be triggered 60
6.7 SMART ECG MONITORS 60
6.7.1 LACK OF DATA SECURITY HINDERS THE GROWTH OF THE SMART MONITORS MARKET TO SOME EXTENT 60

7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE 62
7.1 INTRODUCTION 63
7.2 DEFIBRILLATORS 64
7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 65
7.2.1.1 Transvenous implantable cardioverter defibrillators (T-ICDs) 67
7.2.1.1.1 Biventricular implantable cardioverter defibrillators/cardiac resynchronization therapy defibrillators 68
7.2.1.1.1.1 Biventricular ICDs/CRT-Ds are preferred for heart failure patients 68
7.2.1.1.2 Dual-chamber implantable cardioverter defibrillators 69
7.2.1.1.2.1 Benefits of dual-chamber ICDs, such as higher diagnostic accuracy, make them ideal for patients with tachycardia episodes 69
7.2.1.1.3 Single-chamber implantable cardioverter defibrillators 70
7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs will drive market growth 70
7.2.1.2 Subcutaneous implantable cardioverter defibrillators 70
7.2.1.2.1 Safety and efficacy of S-ICDs in the prevention of sudden cardiac arrest will boost their adoption 70
7.2.2 EXTERNAL DEFIBRILLATORS 71
7.2.2.1 Automated external defibrillators 72
7.2.2.1.1 Semi-automated external defibrillators 73
7.2.2.1.1.1 Semi-automated external defibrillators accounted for the largest share of the AEDs market in 2018 73
7.2.2.1.2 Fully automated external defibrillators 73
7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy will drive market growth 73
7.2.2.2 Manual external defibrillators 73
7.2.2.2.1 North America dominates the manual defibrillators market 73
7.2.2.3 Wearable cardioverter defibrillators 74
7.2.2.3.1 Ease of use and the noninvasive nature of wearable cardioverter defibrillators will support market growth 74
7.3 PACEMAKERS 75
7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY 76
7.3.1.1 Implantable pacemakers 76
7.3.1.1.1 Introduction of leadless and MRI-safe devices has boosted device popularity 76
7.3.1.2 External pacemakers 78
7.3.1.2.1 Increasing number of open-heart surgeries will drive the demand for external pacemakers 78
7.3.2 PACEMAKERS MARKET, BY TYPE 80
7.3.2.1 Dual-chamber pacemakers 80
7.3.2.1.1 Dual-chamber pacemakers are the most commonly implanted pacemakers for bradycardia?a key factor driving market growth 80
7.3.2.2 Single-chamber pacemakers 80
7.3.2.2.1 Introduction of leadless pacemakers will stimulate demand in this product segment 80
7.3.2.3 Biventricular/CRT pacemakers 81
7.3.2.3.1 High cost and unfavorable reimbursement scenario have hindered market growth 81

8 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER 82
8.1 INTRODUCTION 83
8.2 HOSPITALS, CLINICS, & CARDIAC CENTERS 83
8.2.1 GROWING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET GROWTH 83
8.3 AMBULATORY SURGERY CENTERS 85
8.3.1 GROWING NUMBER OF ASCS IN THE US TO DRIVE THE ADOPTION OF CM & CRM DEVICES 85
8.4 OTHER END USERS 87

9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION 89
9.1 INTRODUCTION 90
9.2 NORTH AMERICA 91
9.2.1 US 97
9.2.1.1 Growing number of FDA approvals for CM & CRM devices to support market growth in the US 97
9.2.2 CANADA 99
9.2.2.1 Growing focus of government and private organizations on providing funding for research to drive market growth 99
9.3 EUROPE 101
9.3.1 GERMANY 105
9.3.1.1 Increasing healthcare expenditure to drive market growth 105
9.3.2 FRANCE 107
9.3.2.1 Rising prevalence of heart failure to drive the adoption of CRT devices in France 107
9.3.3 UK 110
9.3.3.1 Rising demand for home-based cardiac monitoring devices to support market growth 110
9.3.4 ITALY 112
9.3.4.1 Increasing incidence of atrial fibrillation among the elderly will drive market growth in Italy 112
9.3.5 SPAIN 114
9.3.5.1 Rising awareness and growing device adoption indicate strong growth in the coming years 114
9.3.6 REST OF EUROPE 115
9.4 ASIA PACIFIC 117
9.4.1 JAPAN 123
9.4.1.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan 123
9.4.2 CHINA 125
9.4.2.1 Rising prevalence of CVDs and government support for infrastructural improvements will drive market growth 125
9.4.3 INDIA 127
9.4.3.1 Government initiatives will propel market growth in India 127
9.4.4 REST OF ASIA PACIFIC 129
9.5 REST OF THE WORLD 131
10 COMPETITIVE LANDSCAPE 135
10.1 OVERVIEW 135
10.2 MARKET SHARE ANALYSIS, 2018 135
10.3 COMPETITIVE SCENARIO 136
10.3.1 CONTRACTS, PARTNERSHIPS, & AGREEMENTS (2016–2019) 136
10.3.2 PRODUCT LAUNCHES & APPROVALS (2016–2019) 137
10.3.3 EXPANSIONS (2016–2019) 137
10.3.4 ACQUISITIONS (2016–2019) 138
10.4 COMPETITIVE LEADERSHIP MAPPING (2019) 138
10.4.1 VENDOR INCLUSION CRITERIA 138
10.4.2 VISIONARY LEADERS 138
10.4.3 DYNAMIC DIFFERENTIATORS 139
10.4.4 EMERGING COMPANIES 139
11 COMPANY PROFILES 140
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 ABBOTT LABORATORIES 140
11.2 MEDTRONIC, PLC 143
11.3 BOSTON SCIENTIFIC CORPORATION 147
11.4 GE HEALTHCARE 150
11.5 KONINKLIJKE PHILIPS N.V. 152
11.6 BIOTRONIK 154
11.7 ASAHI KASEI CORPORATION 157
11.8 MICROPORT SCIENTIFIC CORPORATION 160
11.9 HILL-ROM HOLDINGS 162
11.10 NIHON KOHDEN CORPORATION 164
11.11 SCHILLER 166
11.12 BIOTELEMETRY 168
11.13 ACS DIAGNOSTICS 170
11.14 BPL MEDICAL TECHNOLOGIES 171
11.15 BTL 172
11.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 173
11.17 LEPU MEDICAL TECHNOLOGY 174
11.18 SHREE PACETRONIX 175
11.19 OSYPKA AG 176
11.20 ALIVECOR, INC. 177
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 179
12.1 DISCUSSION GUIDE 179
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 182
12.3 AVAILABLE CUSTOMIZATIONS 184
12.4 RELATED REPORTS 184
12.5 AUTHOR DETAILS 186